Risperidone in levodopa-induced psychosis in advanced parkinson's disease: An open-label, long-term study-Reference-Cited by-同舟云学术

Risperidone in levodopa-induced psychosis in advanced parkinson's disease: An open-label, long-term study

Published:1997-07 Issue:4 Volume:12 Page:610-612
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Meco Giuseppe,Alessandri Andrea,Giustini Patrizia,Bonifati Vincenzo

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference9 articles.

1. Neuropsychiatric complications of drug treatment of Parkinson's disease. In: eds, Parkinson's disease—neurobehavioral aspects. New York: Oxford University Press, 1992: 313-27.

2. Risperidone

3. Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

4. “Mini-mental state”

5. Unified Parkinson's Disease Rating Scale. In: eds. Recent developments in Parkinson's disease, vol 2. Florham Park: Macmillan Healthcare Information, 1987: 153-63.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem);Neurology, Neuropsychiatry, Psychosomatics;2024-06-22

2. Psychosis in Parkinson’s Disease: Looking Beyond Dopaminergic Treatments;Current Pharmaceutical Design;2022-09

3. Pharmacotherapy of Psychosis in Parkinson’s Disease;NeuroPsychopharmacotherapy;2022

4. Pharmacotherapy of Psychosis in Parkinson’s Disease;NeuroPsychopharmacotherapy;2020-12-21

5. Comparison of the association of risperidone and quetiapine with deteriorating performance in walking and dressing in subjects with Parkinson’s disease;International Clinical Psychopharmacology;2019-09